Cardiac rehabilitation is now considered an integral part of the management of cardiac disease. However, the approach to objectives has been variable and not well defined. To have a more structured approach towards the goals and objectives of cardiac rehabilitation, this paper discusses the interrelationship of the different factors which determine quality of life, who are the candidates for rehabilitation, the effectiveness of the various modes of intervention, the interface between the rehabilitation process and traditional medical modes of intervention and evaluation of outcome.
Get full access to this article
View all access options for this article.
References
1.
Naughton J.Cardiac rehabilitation: principles, technics, applications. In: Amsterdam EA ed. Exercise in cardiovascular health and disease. New York: Yorke Medical Books, 1977: 364-76.
2.
Leon AS, Blackburn H.Exercise rehabilitation of the coronary heart disease patient. Geriatrics1977; 32: 66-76.
3.
Oberman A.Rehabilitation of patients with coronary artery disease. In: Braunwald E ed. Heart disease. Philadelphia: WB Saunders, 1984: 1384-98.
4.
Wenger NJRehabilitation of the patient with symptomatic coronary arteriosclerotic heart disease. Baylor College of Medicine Cardiology Series. Princeton, New Jersey, 1980.
5.
Wenger NJAssessment of quality of life in clinical trials of cardiovascular therapies . Am J Cardiol1984; 54: 908-13.
6.
Ware J.Conceptualizing disease impact and treatment outcomes. Cancer1984; 33(Suppl): 2316-26.
7.
Norris RM, Caughey DE, Deeming LW, Marcer CJ, Scott PJCoronary prognostic index for predicting survival after recovery from acute myocardial infarction. Lancet1970; 11: 485-88.
8.
Bigger JT, Heller CA, Wenger TL, Weld SMRisk stratification after acute myocardial infarction. Am J Cardiol1978; 42: 202-10.
9.
DeBusk RF, Kraemer HC, Nash E.Stepwise risk stratification soon after myocardial infarction. Am J Cardiol1983; 52: 1161-66.
10.
TheMulticenter Post-infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med1983; 309: 331-36.
11.
International Classification of Impairments, Disabilities and Handicaps. Geneva: WHO, 1980.
12.
The Committee on Exercise, American Heart Association.Exercise testing and training of apparently healthy individuals: a handbook for physicians. New York: American Heart Association, 1972.
13.
Wood Phn, Badley EMAn epidemiological appraisal of disablement. In: Bennett AE ed. Recent advances in community medicine. Edinburgh: Churchill Livingstone, 1978.
14.
DeBusk RF, Blomgvist CG, Kouchoukos NT et al. Identification and treatment of low risk patients after acute myocardial infarction and coronary artery bypass graft surgery. N Engl J Med1986; 314: 161-66.
15.
Franciosa JA , Park M., Levine TBLack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol1981; 47: 33-39.
16.
Hakki A., Weinreich DJ, DePace NL, Iskandrian ASCorrelation between exercise capacity and left ventricular function in patients with severely depressed left ventricular function. J Cardiac Rehab1984; 4: 38-43.
17.
TheNorwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving after myocardial infarction. N EnglJ Med1981; 304: 801-807.
18.
Hjalmarson A., Elmfeldt D., Herlitz J. et al. Effect on mortality of metoprolol in acute myocardial infarction. Lancet1981; 2: 823-26.
19.
Beta-blocker Heart Attack Study Group, National Heart, Lung and Blood Institute.The Beta-blocker heart attack trial. Preliminary report. JAMA1981 ; 246: 2073-74.
20.
Sherry S., Belver A.Anticoagulants, platelet-controlling drugs and thrombolytic agents. In: Hurst JW ed. The heart. New York: McGraw-Hill Book Co., 1986: 1667-85.
21.
Lewis HD, Davis JW, Archibald DG et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med1983; 309: 397-403.
22.
Cheseboro JH , Clementis IP, Fuster V. et al. A platelet-inhibitor-drug trial in coronary artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med1982; 307: 73-81.
23.
Cheseboro JH , Fuster V., Elveback LR et al. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med1984; 310: 209-14.
24.
May GS, Eberlein KA, Furbergh CD, Passamani ER, DeMets DLSecondary prevention after myocardial infarction: a review of long-term trials . Prog Cardiovasc Dis1982; 24: 331-52.
25.
Chatterjee K., Parmley WWVasodilator therapy for acute myocardial infarction and chronic congestive heart failure. J Am Coll Cardiol0000; 1: 133-53.
26.
Traill TA, Fortuin NGDrug-induced cardiovascular disease. In: Julian D and Humphries JO eds. London: Butterworths, 1983: 176-92.
27.
Hammond HKRegression of ahterosclerosis - a review. J Cardiac Rehab1983; 3: 347-59.
28.
Zir LM, Dinsmore R., Vexeridis M., Singh JB, Harthorne SW, Daggett WMEffects of coronary bypass grafting on resting left ventricular contraction in patients studied one to two years after operation. Am J Cardiol1979; 44: 601-606.
29.
Rahimtoola SHCoronary bypass surgery for chronic angina - 1981. A perspective. Circulation1982; 65: 225-41.
30.
CASS Principal Investigators.A randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. Circulation1983; 68: 951-60.
31.
Takaro T., Hultgren HN, Lipton MJ et al. The VA Cooperative randomized study of surgery for coronary artery occlusive disease. II. Subgroup with significant left main lesions . Circulation1976; 54(Suppl 3): 107.
32.
TheVeterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the veterans administration randomised trial of coronary artery bypass surgery for stable angina pectoris. N Engl J Med1984; 311: 1333-39.
33.
Gruntzig AR , Myler RJ, Hanna ES, Turina MITransluminal angioplasty of coronary artery stenosis (abstract). Circulation1977; 56: 84,
34.
Conn EH, Williams RS, Wallace AGExercise responses before and after physical conditioning in patients with severely depressed left ventricular function. Am J Cardiol1982; 49: 296-300.
35.
Eichner ERExercise and heart disease. Epidemiology of the 'exercise hypothesis'. Am J Med1983; 75: 1008-23.
36.
Cobb LA, Weaver WDExercise: a risk for sudden death in patients with coronary heart disease . J Am Coll Cardiol1986; 7: 215-19.
37.
Aberg A., Bergstrand R., Johansson S. et al. Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J1983; 49: 416-22.
38.
Leren P.The Oslo diet-heart study: 11-year report. Circulation1970; 42: 935.
39.
Arntzenius AC, Kromhout D., Barth JD et al. Diet, lipoproteins, and the regression of coronary atherosclerosis. The Leiden intervention trial. N Engl J Med1985; 312: 805-11.
40.
Levy RICauses of the decrease in cardiovascular mortality. Am J Cardiol1984; 54: 7C-13C.
41.
Kaplan NMTherapy of mild hypertension: an overview. Am J Cardiol1984; 53: 2A-8A.
